HSE defends cancer services

THE HSE has moved to defend prostate cancer service standards after concerns were raised by the independent Irish Cancer Society (ICS).

In a survey, the ICS advocacy group identified serious problems in support and information services for men who have been diagnosed with prostate cancer.

The study found that 98% of men surveyed had side effects as a result of their treatment, including urinary, bowel or sexual issues. More than 54% of those surveyed said the loss of libido after treatment was worse than they had expected.